Results 241 to 250 of about 113,104 (262)

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Molecular Therapy, 2017
Tanya Siddiqi, Nancy L Bartlett, Armin Ghobadi   +2 more
exaly  

Beyond CD19

Advances in Oncology
Erin E. Doherty, Helen E. Heslop
openaire   +1 more source

CD19 regulates B lymphocyte responses to transmembrane signals

Seminars in Immunology, 1998
Manabu Fujimoto, Jonathan Poe, Thomas Tedder   +2 more
exaly  

CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer

Cancer Immunology, Immunotherapy, 2018
Yiwei Wang, Jiejie Xu, Qi Jiang
exaly  

MAb CLB-CD19

Inpharma Weekly, 1991
openaire   +1 more source

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

Cell
Hongjuan Lu, Lingying Ye, Lehang Guo
exaly  

Diphtheria toxin‐based anti‐human CD19 immunotoxin for targeting human CD19+ tumors

Molecular Oncology, 2017
Christene A Huang, Zhirui Wang, Zhaohui Wang   +2 more
exaly  

CD19 Deficiency

2012
openaire   +1 more source

An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis

Cell
Lehang Guo
exaly  

Role of CD19 Signal Transduction in B Cell Biology

Immunologic Research, 2002
Brooks Stephen
exaly